Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	2,656	2,591	3,298	3,439	3,140	2,710	88	810	785	746	264
COGS	11	-378	1,780	2,053	1,684	1,450	0	415	356	276	0
Gross profit	—	—	1,517	1,386	1,455	1,259	—	396	429	470	—
	2,304	2,651	1,023	1,065	1,085	832	95	392	413	438	215
	341	318	494	321	371	427	-7	3	17	32	49
OPM %	12.8%	12.3%	15%	9.3%	11.8%	15.8%	-7.7%	0.4%	2.1%	4.3%	18.5%
Depreciation	87	81	83	86	107	100	6	43	48	53	6
Interest	202	174	135	129	136	102	31	19	30	30	7
	40	52	91	78	172	48	126	138	103	88	37
Profit before tax	91	115	368	183	299	273	82	79	42	38	73
Tax	12	35	104	36	-22	59	4	29	10	18	9
Tax %	13.5%	30.9%	28.4%	19.5%	-7.5%	21.5%	4.6%	37.1%	24.2%	48.9%	12.8%
	79	79	263	148	321	214	79	50	32	19	63
PAT margin %	3%	3.1%	8%	4.3%	10.2%	7.9%	89.5%	6.2%	4%	2.6%	24%
EPS (₹)	5	5	16.5	9.3	20.2	13.5	4.9	3.1	2	1.2	4
EPS adjusted (₹)	5	5	16.5	9.3	20.2	13.5	4.9	3.1	2	1.2	4
	60.5%	60.4%	18.1%	48.5%	24.8%	37.1%	101.4%	159.7%	251.3%	413.2%	125.9%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	16	16	16	16	16	16	16	16	16	16	16
Reserves	1,967	2,027	2,233	2,324	2,591	1,267	2,423	2,399	2,359	2,302	2,296
	2,113	1,564	1,250	1,602	1,951	493	174	302	343	306	50
	947	784	1,125	921	875	69	282	292	275	285	70
Total equity & liabilities	5,042	4,391	4,625	4,864	5,433	1,845	2,896	3,008	2,992	2,910	2,433
	1,448	1,421	1,438	1,491	1,764	100	612	687	662	657	98
CWIP	20	65	115	284	58	0	35	47	37	19	6
Investments	1,776	1,710	1,706	1,764	1,764	1,646	1,646	1,657	1,657	1,657	2,176
	1,798	1,196	1,365	1,325	1,847	98	602	618	637	576	153
Total assets	5,042	4,391	4,625	4,864	5,433	1,845	2,896	3,008	2,992	2,910	2,433

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2021 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Life Science Ingredients	2,709.5	381.5	—	0
Pharmaceuticals	0	0	—	0

SegmentFigure

Life Science Ingredients · revenue

₹ crore by fiscal year

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	164	419	558	182	317	608	-6	-65	143	136	94
	522	-43	-127	-285	-198	178	96	31	-40	-2	34
	-784	-338	-470	85	-41	-782	-107	23	-78	-157	-130
Net cash flow	-98	38	-40	-18	78	5	-18	-12	25	-24	-2
Free cash flow	164	419	558	182	—	516	-8	-125	76	114	74
CFO / Operating profit %	48.2%	131.8%	112.9%	56.6%	85.4%	142.5%	—	—	867.9%	422.4%	191.8%